title: Drug companies should target drug plans, rather than physicians, consultant says.
authors.forename: Ann
authors.initials: A
authors.lastname: Silversides
mesh_terms: D002170:Canada; D003362:Cost-Benefit Analysis; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007349:Insurance, Health, Reimbursement; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D010330:Patents as Topic